Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.29% | 57.45% | -3.99% | -17.48% | -24.87% |
| Total Depreciation and Amortization | -10.92% | -9.34% | -6.31% | -3.86% | -3.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.81% | -81.05% | 361.96% | 308.43% | 270.74% |
| Change in Net Operating Assets | -28.06% | -183.08% | -158.71% | -149.07% | -132.91% |
| Cash from Operations | 21.91% | -50.14% | -67.91% | -92.55% | -122.45% |
| Capital Expenditure | 83.52% | 91.48% | 67.54% | -88.71% | -101.19% |
| Sale of Property, Plant, and Equipment | 213.46% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,123.42% | 2,410.62% | 4,304.00% | 226.91% | -14.66% |
| Cash from Investing | 694.93% | 2,215.19% | 1,074.73% | 185.30% | -38.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -43.24% | -20.15% | -98.81% | -98.75% | -99.04% |
| Repurchase of Common Stock | 90.59% | 86.15% | 67.08% | 54.49% | 55.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 108.38% | 108.38% |
| Cash from Financing | 289.09% | 560.00% | -99.30% | -99.49% | -99.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.16% | 121.44% | 123.35% | -82.95% | -802.68% |